<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebrovascular disease is a major cause of mortality and disability in adults </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000819'>Diabetes mellitus</z:hpo> increases the risk of <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> and is associated with worse clinical outcome following an event </plain></SENT>
<SENT sid="2" pm="."><plain>Upregulation of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) in <z:mp ids='MP_0002055'>diabetes</z:mp> appears to play a role in vascular complications of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>We hypothesised that inhibition of MMP-2 and MMP-9 by <z:chebi fb="1" ids="50694">minocycline</z:chebi> can be potentiated by aspirin through inhibition of cyclooxygenase-2 and tissue plasminogen activator, resulting in amelioration of clinical <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>In the present study, <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e>/reperfusion injury was induced in <z:chebi fb="1" ids="9288">streptozotocin</z:chebi> diabetic rats by 1 h middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and 24 h reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume, cerebral <z:hpo ids='HP_0000969'>oedema</z:hpo>, neurological severity score and blood-brain barrier disruption were significantly increased in diabetic animals compared with the normoglycemic control group </plain></SENT>
<SENT sid="6" pm="."><plain>The combination of aspirin and <z:chebi fb="1" ids="50694">minocycline</z:chebi> treatment significantly improved these parameters in diabetic animals </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, this therapy was associated with significantly lower mortality and reduction in MMP-2 and MMP-9 levels </plain></SENT>
<SENT sid="8" pm="."><plain>Our data indicate that combination of aspirin and <z:chebi fb="1" ids="50694">minocycline</z:chebi> therapy protects from the consequences of <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> in animal models of <z:mp ids='MP_0002055'>diabetes</z:mp> and is associated with inhibition of MMP-2 and MMP-9 </plain></SENT>
<SENT sid="9" pm="."><plain>Therefore, this combination therapy may represent a novel strategy to reduce the neurological complications of <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>